New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 19, 2012
10:41 EDTAKS, CPHD, DMND, DRYS, LRN, LH, MTL, PNNT, VFCOn The Fly: Analyst Downgrade Summary
Today’s notable downgrades include: AK Steel (AKS) downgraded to Neutral from Buy at Longbow...Cepheid (CPHD) downgraded to Neutral from Buy at Goldman...Diamond Foods (DMND) downgraded to Underperform from Hold at Jefferies...DryShips (DRYS) downgraded to Market Perform from Outperform at Wells Fargo...K12 (LRN) downgraded to Market Perform from Outperform at Wells Fargo...LabCorp (LH) downgraded to Sell from Neutral at Goldman...Mechel (MTL) downgraded to Equal Weight from Overweight at Morgan Stanley...PennantPark (PNNT) downgraded to Neutral from Outperform at RW Baird...VF Corp. (VFC) downgraded to Neutral from Buy at DA Davidson.
News For AKS;CPHD;DMND;DRYS;LRN;LH;MTL;PNNT;VFC From The Last 14 Days
Check below for free stories on AKS;CPHD;DMND;DRYS;LRN;LH;MTL;PNNT;VFC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
17:39 EDTCPHDCepheid sees Q2 revenue $113M-$115M, consensus $110.68M.
Subscribe for More Information
16:10 EDTCPHDCepheid sees FY14 non-GAAP EPS 19c-24c, may not compare with consensus (24c)
Sees FY14 revenue in the range of $446M-$461M. Sees FY14 net loss in a range from $(0.43) to $(0.38) per share. Expected non-GAAP net income excludes approximately $33M related to stock compensation expense, approximately $9M related to the amortization of debt discount and debt issuance costs, and approximately $3M related to the amortization of acquired intangibles.
16:07 EDTCPHDCepheid reports Q1 non-GAAP EPS (1c), may not compare with consensus (17c)
Subscribe for More Information
15:29 EDTCPHDNotable companies reporting after market close
Notable companies reporting before tomorrow's market open, with earnings consensus, include athenahealth (ATHN), consensus 17c; Allison Transmission (ALSN), consensus 31c; Investors Bancorp (ISBC), consensus 24c; Cepheid (CPHD), consensus (17c); Advanced Micro Devices (AMD), consensus 0c; Associated Banc-Corp (ASBC), consensus 25c; Hub Group (HUBG), consensus 36c; Capital Bank (CBF), consensus 24c; Select Comfort (SCSS), consensus 32c; Acacia Research (ACTG), consensus 4c.
08:32 EDTLHARCA Biopharma announces screening of first patient in Phase 2B/3 trial
ARCA biopharma announced that the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 adaptive design clinical trial. The GENETIC-AF trial will evaluate Gencaro as a potential treatment for the prevention of atrial fibrillation in patients with heart failure and/or left ventricular dysfunction who also have a specific genotype of the beta-1 adrenergic receptor, which is believed to be present in approximately 50% of the U.S. population. There are currently seven active clinical trial sites recruiting patients for GENETIC-AF. The company anticipates having approximately 50 clinical trial sites for the Phase 2B portion of the trial. Last week, ARCA hosted the initial GENETIC-AF Investigator Meeting which brought together the physicians and research coordinators participating in the trial for information sharing and study-specific training.
07:31 EDTVFCLululemon faces increased competition in yogawear industry, Reuters says
Subscribe for More Information
April 15, 2014
12:51 EDTAKSAK Steel boosts stainless steel prices
Subscribe for More Information
April 10, 2014
07:03 EDTCPHDCepheid announces European release of Xpert Norovirus
Cepheid announced the release of Xpert Norovirus, a qualitative in vitro diagnostic test for rapid identification and differentiation of Noroviruses genogroup I and genogroup II, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert System.
06:14 EDTMTLMechel reports joint project with Russia's Federal Labor and Employment Service
Mechel announces the launch of a pilot project on stepping up the efficiency of measures for improvement of labor conditions at the Group's enterprises. The project will be implemented jointly with Russia's Federal Labor and Employment Service as part of that agency's new activity model – Open Labor Inspection, which is due to be set up in the Russian Federation by 2018. As part of the project, a monitoring will be held in 2014, analyzing work conditions and labor safety systems in 21 of Mechel's facilities. As a result, a comprehensive plan for improving work conditions will be designed, taking into account the newest amendments to Russian labor law.
April 9, 2014
08:37 EDTMTLMechel signs contract for engineering for Elga coal project first stage
Mechel OAO announces signing a contract with Austria's Binder company for engineering services on designing the technological coal drying line for Elga Coal Complex's first stage. According to the contract, Binder assumes obligations as to designing the coal drying line which will be enclosed in the production cycle at the washing plant with the annual capacity of 9M tonnes of coking coal. This plant is part of Elga Coal Complex's first stage, and its construction is scheduled to begin in the first quarter of 2015. Project works are due to be completed by the end of 2014, when the decision on whether to extend cooperation with Binder to include supplies of project equipment for the washing plant will be made. The equipment's cost is estimated to total some EUR50M.
07:48 EDTAKSBofA/Merrill's steel analysts hold an analyst/industry conference call
Subscribe for More Information
06:48 EDTCPHDCepheid upgraded to Outperform from Market Perform at JMP Securities
Subscribe for More Information
06:00 EDTCPHDCepheid upgraded to Outperform from Market Perform at JMP Securities
Subscribe for More Information
April 7, 2014
16:42 EDTAKSAK Steel announces price increase for hot roll carbon steel
AK Steel said that it will increase the current spot market base price for its hot roll carbon steel to a minimum of $700 per ton, effective immediately with new orders.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use